vs

Side-by-side financial comparison of FRANKLIN WIRELESS CORP (FKWL) and SUTRO BIOPHARMA, INC. (STRO). Click either name above to swap in a different company.

FRANKLIN WIRELESS CORP is the larger business by last-quarter revenue ($11.9M vs $11.6M, roughly 1.0× SUTRO BIOPHARMA, INC.). On growth, SUTRO BIOPHARMA, INC. posted the faster year-over-year revenue change (-21.4% vs -33.1%). Over the past eight quarters, FRANKLIN WIRELESS CORP's revenue compounded faster (39.0% CAGR vs -5.4%).

Viaero Wireless is a regional wireless telecommunications company that provides direct coverage in Nebraska, eastern Colorado, western Kansas, and southeastern Wyoming. Based in Fort Morgan, Colorado, Viaero is often the primary cell tower owner in portions of its coverage area. Through roaming coverage partner relationships, Viaero customers can place and receive calls locally and across the country, internationally, and on cruise ships.

Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in 2003 under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in 2009. William Newell, CEO as of 2024, joined Sutro in Ja...

FKWL vs STRO — Head-to-Head

Bigger by revenue
FKWL
FKWL
1.0× larger
FKWL
$11.9M
$11.6M
STRO
Growing faster (revenue YoY)
STRO
STRO
+11.7% gap
STRO
-21.4%
-33.1%
FKWL
Faster 2-yr revenue CAGR
FKWL
FKWL
Annualised
FKWL
39.0%
-5.4%
STRO

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
FKWL
FKWL
STRO
STRO
Revenue
$11.9M
$11.6M
Net Profit
$533.6K
Gross Margin
17.1%
Operating Margin
0.4%
Net Margin
4.5%
Revenue YoY
-33.1%
-21.4%
Net Profit YoY
133.3%
35.4%
EPS (diluted)
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FKWL
FKWL
STRO
STRO
Q4 25
$11.9M
$11.6M
Q3 25
$12.7M
$9.7M
Q2 25
$6.9M
$63.7M
Q1 25
$8.0M
$17.4M
Q4 24
$17.8M
$14.8M
Q3 24
$13.3M
$8.5M
Q2 24
$6.1M
$25.7M
Q1 24
$6.2M
$13.0M
Net Profit
FKWL
FKWL
STRO
STRO
Q4 25
$533.6K
Q3 25
$640.5K
$-56.9M
Q2 25
$-342.2K
$-11.5M
Q1 25
$-644.8K
$-76.0M
Q4 24
$228.7K
$-72.4M
Q3 24
$515.2K
$-48.8M
Q2 24
$-1.8M
$-48.0M
Q1 24
$-1.2M
$-58.2M
Gross Margin
FKWL
FKWL
STRO
STRO
Q4 25
17.1%
Q3 25
22.8%
Q2 25
18.0%
Q1 25
16.9%
Q4 24
18.2%
Q3 24
15.5%
Q2 24
10.5%
Q1 24
8.4%
Operating Margin
FKWL
FKWL
STRO
STRO
Q4 25
0.4%
Q3 25
4.6%
-499.9%
Q2 25
-19.0%
-5.2%
Q1 25
-24.6%
-393.8%
Q4 24
4.5%
-440.7%
Q3 24
-2.8%
-797.2%
Q2 24
-36.7%
-189.4%
Q1 24
-25.2%
-435.0%
Net Margin
FKWL
FKWL
STRO
STRO
Q4 25
4.5%
Q3 25
5.0%
-586.6%
Q2 25
-4.9%
-18.0%
Q1 25
-8.1%
-436.6%
Q4 24
1.3%
-489.2%
Q3 24
3.9%
-572.6%
Q2 24
-28.9%
-186.8%
Q1 24
-19.0%
-447.5%
EPS (diluted)
FKWL
FKWL
STRO
STRO
Q4 25
$0.05
Q3 25
$0.05
$-0.67
Q2 25
$-0.03
$-0.14
Q1 25
$-0.05
$-0.91
Q4 24
$0.02
$-27.63
Q3 24
$0.04
$-0.59
Q2 24
$-0.16
$-0.59
Q1 24
$-0.10
$-0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FKWL
FKWL
STRO
STRO
Cash + ST InvestmentsLiquidity on hand
$24.3M
$141.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$35.1M
$-132.5M
Total Assets
$53.0M
$173.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FKWL
FKWL
STRO
STRO
Q4 25
$24.3M
$141.4M
Q3 25
$25.3M
$167.6M
Q2 25
$25.9M
$205.1M
Q1 25
$25.3M
$249.0M
Q4 24
$21.9M
$316.9M
Q3 24
$40.7M
$388.3M
Q2 24
$37.5M
$375.6M
Q1 24
$31.7M
$267.6M
Stockholders' Equity
FKWL
FKWL
STRO
STRO
Q4 25
$35.1M
$-132.5M
Q3 25
$35.1M
$-87.3M
Q2 25
$34.5M
$-32.1M
Q1 25
$35.3M
$-25.8M
Q4 24
$36.0M
$44.6M
Q3 24
$35.8M
$111.2M
Q2 24
$35.1M
$152.2M
Q1 24
$36.9M
$98.0M
Total Assets
FKWL
FKWL
STRO
STRO
Q4 25
$53.0M
$173.8M
Q3 25
$53.3M
$209.7M
Q2 25
$51.3M
$262.4M
Q1 25
$49.7M
$321.4M
Q4 24
$54.5M
$387.2M
Q3 24
$51.6M
$451.8M
Q2 24
$46.7M
$489.0M
Q1 24
$50.0M
$403.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FKWL
FKWL
STRO
STRO
Operating Cash FlowLast quarter
$-4.1M
$-177.2M
Free Cash FlowOCF − Capex
$-4.1M
FCF MarginFCF / Revenue
-34.3%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
-7.66×
TTM Free Cash FlowTrailing 4 quarters
$-9.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FKWL
FKWL
STRO
STRO
Q4 25
$-4.1M
$-177.2M
Q3 25
$-1.5M
$-38.2M
Q2 25
$2.3M
$-44.7M
Q1 25
$-5.9M
$-67.9M
Q4 24
$2.7M
$-71.7M
Q3 24
$2.7M
$-64.5M
Q2 24
$6.2M
$9.5M
Q1 24
$-779.0K
$-64.7M
Free Cash Flow
FKWL
FKWL
STRO
STRO
Q4 25
$-4.1M
Q3 25
$-1.5M
Q2 25
$2.3M
Q1 25
$-5.9M
Q4 24
$2.7M
Q3 24
$2.6M
Q2 24
$6.2M
Q1 24
$-816.0K
FCF Margin
FKWL
FKWL
STRO
STRO
Q4 25
-34.3%
Q3 25
-11.7%
Q2 25
33.6%
Q1 25
-73.7%
Q4 24
15.4%
Q3 24
19.9%
Q2 24
101.3%
Q1 24
-13.2%
Capex Intensity
FKWL
FKWL
STRO
STRO
Q4 25
0.1%
Q3 25
0.0%
Q2 25
0.1%
Q1 25
0.0%
Q4 24
0.0%
Q3 24
0.2%
Q2 24
0.0%
Q1 24
0.6%
Cash Conversion
FKWL
FKWL
STRO
STRO
Q4 25
-7.66×
Q3 25
-2.32×
Q2 25
Q1 25
Q4 24
11.99×
Q3 24
5.18×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons